Author:
Quinzler Renate,Schmitt Simon PW,Pritsch Maria,Kaltschmidt Jens,Haefeli Walter E
Abstract
Abstract
Background
Currently ambulatory patients break one in four tablets before ingestion. Roughly 10% of them are not suitable for splitting because they lack score lines or because enteric or modified release coating is destroyed impairing safety and effectiveness of the medication. We assessed impact and safety of computerised decision support on the inappropriate prescription of split tablets.
Methods
We performed a prospective intervention study in a 1680-bed university hospital. Over a 15-week period we evaluated all electronically composed medication regimens and determined the fraction of tablets and capsules that demanded inappropriate splitting. In a subsequent intervention phase of 15 weeks duration for 10553 oral drugs divisibility characteristics were indicated in the system. In addition, an alert was generated and displayed during the prescription process whenever the entered dosage regimen demanded inappropriate splitting (splitting of capsules, unscored tablets, or scored tablets unsuitable for the intended fragmentation).
Results
During the baseline period 12.5% of all drugs required splitting and 2.7% of all drugs (257/9545) required inappropriate splitting. During the intervention period the frequency of inappropriate splitting was significantly reduced (1.4% of all drugs (146/10486); p = 0.0008). In response to half of the alerts (69/136) physicians adjusted the medication regimen. In the other half (67/136) no corrections were made although a switch to more suitable drugs (scored tablets, tablets with lower strength, liquid formulation) was possible in 82% (55/67).
Conclusion
This study revealed that computerised decision support can immediately reduce the frequency of inappropriate splitting without introducing new safety hazards.
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Health Policy,Computer Science Applications
Reference21 articles.
1. Gee M, Hasson NK, Hahn T, Ryono R: Effects of a tablet-splitting program in patients taking HMG-CoA reductase inhibitors: analysis of clinical effects, patient satisfaction, compliance, and cost avoidance. J Manag Care Pharm. 2002, 8: 453-8.
2. Hamer AM, Hartung DM, Haxby DG, Ketchum KL, Pollack DA: Initial results of the use of prescription order change forms to achieve dose form optimization (consolidation and tablet splitting) of SSRIantidepressants in a state Medicaid program. J Manag Care Pharm. 2006, 12: 449-56.
3. Parra D, Beckey NP, Raval HS, Schnacky KR, Calabrese V, Coakley RW, Goodhope RC: Effect of splitting simvastatin tablets for control of low-density lipoprotein cholesterol. Am J Cardiol. 2005, 95: 1481-3. 10.1016/j.amjcard.2005.02.019.
4. Stafford RS, Radley DC: The potential of pill splitting to achieve cost savings. Am J Manag Care. 2003, 8: 706-12.
5. Fischbach MS, Gold JL, Lee M, Dergal JM, Litner GM, Rochon PA: Pill-splitting in a long-term care facility. CMAJ. 2001, 164: 785-6.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献